DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $894,465 | +2.8% | 3,370 | 0.0% | 0.07% | -5.6% |
| Q3 2022 | $870,000 | +1.9% | 3,370 | 0.0% | 0.07% | +12.7% |
| Q2 2022 | $854,000 | -22.8% | 3,370 | -10.6% | 0.06% | -8.7% |
| Q1 2022 | $1,106,000 | -10.8% | 3,770 | 0.0% | 0.07% | -5.5% |
| Q4 2021 | $1,240,000 | +5.8% | 3,770 | -2.1% | 0.07% | -5.2% |
| Q3 2021 | $1,172,000 | +11.1% | 3,850 | -2.0% | 0.08% | +13.2% |
| Q2 2021 | $1,055,000 | +19.2% | 3,930 | 0.0% | 0.07% | +13.3% |
| Q1 2021 | $885,000 | -2.3% | 3,930 | -3.7% | 0.06% | -3.2% |
| Q4 2020 | $906,000 | +2.6% | 4,080 | -0.5% | 0.06% | -3.1% |
| Q3 2020 | $883,000 | +21.3% | 4,100 | -0.4% | 0.06% | +10.3% |
| Q2 2020 | $728,000 | +27.7% | 4,115 | 0.0% | 0.06% | +11.5% |
| Q1 2020 | $570,000 | -9.8% | 4,115 | 0.0% | 0.05% | +6.1% |
| Q4 2019 | $632,000 | +6.4% | 4,115 | 0.0% | 0.05% | 0.0% |
| Q3 2019 | $594,000 | -24.8% | 4,115 | -25.5% | 0.05% | -27.9% |
| Q2 2019 | $790,000 | -1.1% | 5,525 | -8.8% | 0.07% | -4.2% |
| Q1 2019 | $799,000 | +18.2% | 6,055 | -7.6% | 0.07% | +4.4% |
| Q4 2018 | $676,000 | -6.1% | 6,555 | -1.1% | 0.07% | +1.5% |
| Q3 2018 | $720,000 | +5.3% | 6,630 | -4.3% | 0.07% | -2.9% |
| Q2 2018 | $684,000 | +0.7% | 6,930 | 0.0% | 0.07% | +1.5% |
| Q1 2018 | $679,000 | +3.7% | 6,930 | -1.8% | 0.07% | +9.7% |
| Q4 2017 | $655,000 | +9.3% | 7,055 | +1.1% | 0.06% | +1.6% |
| Q3 2017 | $599,000 | +11.8% | 6,980 | +9.8% | 0.06% | +8.9% |
| Q2 2017 | $536,000 | -1.5% | 6,355 | 0.0% | 0.06% | -1.8% |
| Q1 2017 | $544,000 | +6.2% | 6,355 | -3.3% | 0.06% | 0.0% |
| Q4 2016 | $512,000 | +0.8% | 6,575 | +1.5% | 0.06% | +3.6% |
| Q3 2016 | $508,000 | -16.6% | 6,475 | +7.5% | 0.06% | -16.7% |
| Q2 2016 | $609,000 | +6.5% | 6,025 | 0.0% | 0.07% | +3.1% |
| Q1 2016 | $572,000 | +11.9% | 6,025 | +9.5% | 0.06% | +14.3% |
| Q4 2015 | $511,000 | +56.3% | 5,500 | +43.2% | 0.06% | +47.4% |
| Q3 2015 | $327,000 | – | 3,840 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |